XML 21 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
4. Debt
12 Months Ended
Dec. 31, 2016
Debt Disclosure [Abstract]  
4. Debt

Note 4 – Debt

 

Debt consists of the following:

 

    December 31,
Description Note 2016 2015
Line of credit A $ 47,000 $ 47,000
Note payable to distribution partner B 550,000 550,000
Investor debt C 371,507 267,787
Related party debt D 6,719,979 5,632,543
Other notes payable E 981,137 66,786
Cash draw agreements F 211,076 204,423
Convertible promissory notes G 71,637 154,437
  Total   8,952,336 6,922,976
Less:  unamortized discount and debt issuance costs   (280,555) (173,668)
Debt, net of unamortized discount and debt issuance costs   8,671,781 6,479,308
Less:  current portion   (8,451,781) (5,156,305)
Debt, long-term portion   $ 220,000 $ 1,593,003

 

A – Line of Credit – We utilized this entire bank line of credit for working capital purposes. The outstanding obligation is due on demand, has a stated initial interest rate of 10.5% that is subject to adjustment, and is guaranteed by our majority shareholder/CEO. Energie and our CEO (collectively, “the defendants”) were served with a summons and complaint, wherein the bank brought an action to collect the amount due, including interest, costs and attorney’s fees. On April 4, 2016, the parties to this action entered into a settlement agreement whereby the defendants agreed to pay to Vectra Bank the sum of $59,177 on or before April 30, 2016. This payment was not made and the bank requested and received a judgment against both defendants jointly and severally for $61,502 plus interest of 5.25% per annum plus 9.90% per annum on the default margin.

 

B Note Payable to Distribution Partner – Note payable to a significant European distribution partner, entered into in October 2014, bearing interest at 5% payable quarterly, with principal payable monthly through September 2019.

 

C Investor Debt – Notes payable to lenders having an ownership interest in Holdings at December 31, 2016 and 2015. These loans are not collateralized. The following summarizes the terms and balances of the investor debt:

 

 

December 31,  
2016 2015 Interest Rate
$ 87,787 $ 87,787 24%
50,000 50,000 24%
50,000 50,000 24%
25,000 25,000 8%
25,000 25,000 8%
20,000 20,000 2%
113,720 10,000 various
$ 351,507 $ 267,787  

 

 

D – Related Party Debt – The following summarizes notes payable to related parties.

 

  December 31,  
  2016 2015 Interest Rate
D1 $ 4,635,865 $ 4,120,465 various
D2 -- 528,214 various
D3 34,888 34,888 12%
D4 356,550 280,800 various
D5 668,176 668,176 18%
D6 1,024,500 -- 6%
Total $ 6,719,979 $ 5,632,543  

 

D1 – Notes payable to Symbiote, Inc. (“Symbiote”), entered into from December 2014 to June 2016, with monthly principal and interest payable through November 2017. Symbiote is an owner of the common stock of Holdings, is the lessor of our manufacturing facility, and the provider of our payroll services. We also owe Symbiote $315,815 in accounts payable.

 

D2 – Notes payable to a former executive vice president, entered into from December 2014 through December 2015, with monthly principal and interest payable through November 2017. As of December 31, 2016, this individual is no longer employed by Holdings and is no longer considered a related party.

 

D3 – Note payable to our chief executive officer (“CEO”), entered into in December 2014, with monthly principal and interest payable through December 2016. We also owe Hal $700,391 in accrued compensation and expense incurred on behalf of the Company.

 

D4 – Notes payable to the spouse of our CEO, entered into from September 2013 to November 2016, with principal and interest payments due upon a specific event or upon demand.

 

D5 – Notes payable to the consulting firm that employs our Chief Financial Officer, entered into from June 2015 to December 2015. These notes aggregated the previous accounts payable and accrued interest due to the consulting firm at the time the notes were made. As of January 1, 2016, the notes are convertible into shares of our common stock at a conversion rate of 75% of the volume weighted average market price of our stock over the 20 days preceding the notification of conversion. We determined that this conversion feature does not meet the requirements to be treated as a derivative; however, we did determine it was a beneficial conversion feature. Accordingly, we recorded a debt discount of $217,725, which was amortized through interest expense over the life of the notes. We also owe NOW CFO $436,786 in accounts payable.

 

D6 – Notes payable to the principal shareholders of Symbiote, entered into from April to December 2016, with principal and interest payments due upon a specific event or upon demand.

 

E Other Notes Payable – Represents the outstanding principal balance on four separate notes bearing interest at between 6% and 24% annually. In the event we receive proceeds as the beneficiary of a life insurance policy covering our majority shareholder/CEO, repayment of principal and interest is due on one of these notes prior to using the proceeds for any other purpose.

 

F – Cash draw agreements – Under these agreements, the lender advances us the principal balance and then automatically withdraws a stated amount each business day. Accordingly, there is no stated interest rate. The total remaining daily payments due under these arrangements was $285,131 as of December 31, 2016. The maturity dates of the agreements range from February to May 2017.

 

G Convertible promissory notes – Represents the outstanding principal balance on two separate convertible promissory notes payable to an entity with interest of 8% annually, that were due in August 2016. During the third quarter of 2015, the current holder of the notes purchased all of our similar outstanding convertible notes from another entity and consolidated those notes into two new notes. At the option of the holder, the notes may be settled in cash or converted into shares of our common stock at any time beginning 180 days from the date of the notes at a price equal to 61% of the average closing bid price of our common stock during the 10 trading days immediately preceding the date of conversion. In the event we fail to pay the notes when they become due, the balance due under the notes incurs interest at the rate of 22% per annum. The notes contain additional terms and conditions normally included in instruments of this kind, including a right of first refusal wherein we have granted the holders the right to match the terms of any future financing in which we engage on the same terms and contemplated in such future financing. We estimate that the fair value of the conversion feature is minimal, so no value has been assigned to the beneficial conversion feature. During the year ended December 31, 2016, $82,800 of principal and $5,661 of accrued interest was converted into 135,532,715 shares of common stock. We also recorded a loss on conversion of debt of $114,791 related to these transactions. Subsequent to December 31, 2016, we paid off the remaining $12,700 of principal on one of the notes leaving one note outstanding as of the date of this report.

 

Debt issuance costs of $280,555 are being amortized over the life of their respective notes.

 

The future maturities of debt are as follows:

 

Year ending December 31,  
2017 $ 8,451,781
2018 120,000
2019 100,000
  $ 8,671,781